Placing
11 December 2003 - 1:17AM
UK Regulatory
RNS Number:0991T
ReGen Therapeutics PLC
10 December 2003
ReGen Therapeutics Plc
10th December 2003
ReGen Therapeutics Plc Placing raises #655,000
ReGen Therapeutics Plc ("ReGen" or "the Company") announces that it has today
placed with new and existing shareholders 32.6 million new ordinary shares ("New
Shares") at 2p per share to raise #652,000 before expenses ("Placing").
Application has been made for the New Shares to be admitted to the Alternative
Investment Market of the London Stock Exchange Plc and dealings are expected to
commence at 8am on 16th December 2003.
Executive Chairman Percy Lomax commented "The Placing price of 2p is one third
higher than the last placing in July and compares very favourably with the 0.75p
placing price in April. During the current year the Company has raised #2.6m. I
am very pleased to see the company in a financial position to continue the
current Research and Development programme."
For further information please contact:
Andrew Marshall
Marshall Robinson Roe
Tel No 020 7960 6007
This information is provided by RNS
The company news service from the London Stock Exchange
END
IOEZBLFFXLBFFBQ